Pharmaceutical Advertising Motivates Patients to Learn More

A massive opportunity in the healthcare marketing industry to use advertising as a tool for public health?

DeepIntent, an independent healthcare marketing technology company, released survey findings that reveal new insight into patient sentiment related to pharmaceutical advertising and the headwinds marketers face in trying to deliver relevant content.

Building on research conducted earlier this year, DeepIntent surveyed 1,244 U.S. patients in August 2021 and found that pharmaceutical ads can empower patients to take a more active role in researching treatments. In addition, advertising influences patients' decision to follow through in taking drugs prescribed by their doctors. After seeing a pharmaceutical ad, patients' most common action is conducting research, which they state as the most common factor influencing their medication adherence behavior. This finding ranks higher than their previous experience taking the same drug.

However, the research also found that marketers face significant challenges in reaching the right groups of patients with relevant information. Despite the pharmaceutical industry's success in researching, producing, and distributing multiple COVID-19 vaccines in less than a year, public approval of pharmaceutical companies has remained flat, and nearly half of respondents don't trust information from pharmaceutical companies. Amid the challenge to capture patients' attention while overcoming their distrust of ads and the pharmaceutical industry, the research shows several paths to better connect with patients.

The insights from the report highlight a massive opportunity in the healthcare marketing industry to use advertising as a tool for public health. Over the past several years, the healthcare data ecosystem has been undergoing a transformative change and with real-world health data, real-time programmatic advertising, and modern technologies like artificial intelligence, marketers can engage both patients and providers in a more personalized, effective way

Inspiration/Source/References

RECENT POSTS

AI’s Transformational Impact on the Patient-Physician Relationship.

The Transformational Impact of Artificial Intelligence on the Relationship Between Physicians and Patients.In today’s ever-evolving healthcare landscape, the integration of…

What is Medical Communications? The definitive guide.

Medical Communications. The demand for clear and integrated dissemination of scientific knowledge is critical for the Pharmaceutical industry. Medical communications—or…

Enhancing engagement with healthcare professionals (HCPs): How AI is transforming Pharma relationships.

Pharmaceutical companies are progressively turning to the use of Artificial Intelligence (AI) as a tool to transform several aspects of…

Six communication trends Pharma needs to watch in 2024.

Six Communication trends Pharma needs to watch in 2024.As we approach 2024, the Pharma industry’s focus on developing and maintaining…

The EU Artificial Intelligence Act: A New Era of Regulation 
The EU's proposed AI Act, the world's first comprehensive legal framework for AI, is set to revolutionize global AI regulation. Learn about its risk classification levels and the potential implications for the Life Sciences industry.
0 +

YEARS IN

MARKET

0 +

THERAPY

AREAS

WORK IN

0 +

COUNTRIES


GET IN TOUCH

Whether you’re looking for effective solutions to transition F2F meetings to a virtual or online environment, support with clinical trials, medical advisory boards, symposia, key opinion leader (KOL) management, internal medical training, medical writing or speaker training programs and more, count on our 16-year experience and expertise over 40 therapeutic areas.

SDM also offers strategic consulting services and can help with communication and engagement of your target audiences as part of market development opportunities.

Discover why over 95% of clients are “Extremely Satisfied” with SDM and over 90% say the agency deliver “Much more than expected”.